Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid

Brain Research

Volumn 1357, Issue , 2010, Pages 175-183

  Gabelle, Audrey ^a,b,c   Roche, Stéphane ^d   Gény, Christian ^a   Bennys, Karim ^a   Labauge, Pierre ^e   Tholance, Yannick ^f   Quadrio, Isabelle ^f   Tiers, Laurent ^d   Gor, Baptiste ^d   Chaulet, Chloé ^a   Vighetto, Alain ^f,h   Croisile, Bernard ^f,h   Krolak Salmon, Pierre ^g,i   Touchon, Jacques ^a,b   Perret Liaudet, Armand ^f   Lehmann, Sylvain ^b,c,d  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c INSTITUTE OF HUMAN GENETICS   (France)

^d HÔPITAL SAINT ELOI   (France)

^e DEPARTMENT OF NEUROLOGY   (France)

^f UNIVERSITÉ LYON 1   (France)

^g Hopital des Charpennes CHU de Lyon   (France)

^h HOSPICES CIVILS DE LYON   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Alzheimer disease; A fragment peptides; Biomarkers; CSF; Dementia; Soluble amyloid precursor proteins

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; SOLUBLE AMYLOID BETA PRECURSOR PROTEIN ALPHA; SOLUBLE AMYLOID BETA PRECURSOR PROTEIN BETA; UNCLASSIFIED DRUG;

ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; PATIENT; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 77957267776     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.08.022     Document Type: Article

References (34)

1. O. Almkvist, H. Basun, S.L. Wagner, B.A. Rowe, L.O. Wahlund, and L. Lannfelt Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation Arch. Neurol. 54 1997 641 644 (Pubitemid 27204251)
2. K. Blennow, and H. Hampel CSF markers for incipient Alzheimer's disease Lancet Neurol. 2 2003 605 613 (Pubitemid 37162569)
3. K. Blennow CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment Expert Rev. Mol. Diagn. 5 2005 661 672 (Pubitemid 41337462)
4. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403 (Pubitemid 44108123)
5. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O'Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P.J. Visser, and P. Scheltens Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6 2007 734 746 (Pubitemid 47058377)
6. A. Gabelle, S. Roche, and S. Lehmann CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders Rev. Neurol. (Paris) 165 2009 213 222
7. Groups, T.L.a.M. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups J. Neurol. Neurosurg. Psychiatry 57 1994 416 418
8. S.K. Herukka, S. Helisalmi, M. Hallikainen, S. Tervo, H. Soininen, and T. Pirttila CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI Neurobiol. Aging 28 2007 507 514 (Pubitemid 46299006)
9. C. Hock, S. Golombowski, F. Muller-Spahn, W. Naser, K. Beyreuther, U. Monning, D. Schenk, C. Vigo-Pelfrey, A.M. Bush, R. Moir, R.E. Tanzi, J.H. Growdon, and R.M. Nitsch Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression-inverse correlation with dementia severity Eur. Neurol. 39 1998 111 118 (Pubitemid 28069802)
10. F. Hulstaert, K. Blennow, A. Ivanoiu, H.C. Schoonderwaldt, M. Riemenschneider, P.P. De Deyn, C. Bancher, P. Cras, J. Wiltfang, P.D. Mehta, K. Iqbal, H. Pottel, E. Vanmechelen, and H. Vanderstichele Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1999 1555 1562 (Pubitemid 29220627)
11. B. Ibach, H. Binder, M. Dragon, S. Poljansky, E. Haen, E. Schmitz, H. Koch, A. Putzhammer, H. Kluenemann, W. Wieland, and G. Hajak Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample Neurobiol. Aging 27 2006 1202 1211 (Pubitemid 44067302)
12. T. Iwatsubo, M. Hasegawa, and Y. Ihara Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics Acta Neuropathol. 88 1994 129 136 (Pubitemid 24233243)
13. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 325 1987 733 736 (Pubitemid 17054046)
14. L. Lannfelt, H. Basun, L.O. Wahlund, B.A. Rowe, and S.L. Wagner Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease Nat. Med. 1 1995 829 832
15. S. Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.L. Beaudeux, F. Berger, F. Betsou, J. Borg, A. Dupuy, J. Garin, M. Quillard, G. Lizard, K. Peoc'h, M. Riviere, and P. Ducoroy Preanalytical guidelines for clinical proteomics investigation of biological fluids Ann. Biol. Clin. (Paris) 67 2009 629 639
16. P. Lewczuk, H. Kamrowski-Kruck, O. Peters, I. Heuser, F. Jessen, J. Popp, K. Burger, H. Hampel, L. Frolich, S. Wolf, B. Prinz, H. Jahn, C. Luckhaus, R. Perneczky, M. Hull, J. Schroder, H. Kessler, J. Pantel, H.J. Gertz, H.W. Klafki, H. Kolsch, U. Reulbach, H. Esselmann, J.M. Maler, M. Bibl, J. Kornhuber, and J. Wiltfang Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study Mol. Psychiatry 15 2010 138 145
17. N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S.K. Herukka, W.M. van der Flier, M.A. Blankenstein, M. Ewers, K. Rich, E. Kaiser, M. Verbeek, M. Tsolaki, E. Mulugeta, E. Rosen, D. Aarsland, P.J. Visser, J. Schroder, J. Marcusson, M. de Leon, H. Hampel, P. Scheltens, T. Pirttila, A. Wallin, M.E. Jonhagen, L. Minthon, B. Winblad, and K. Blennow CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 2009 385 393 (Pubitemid 43202329)
18. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, H. Feldman, J. Cummings, J.E. Duda, C. Lippa, E.K. Perry, D. Aarsland, H. Arai, C.G. Ballard, B. Boeve, D.J. Burn, D. Costa, T. Del Ser, B. Dubois, D. Galasko, S. Gauthier, C.G. Goetz, E. Gomez-Tortosa, G. Halliday, L.A. Hansen, J. Hardy, T. Iwatsubo, R.N. Kalaria, D. Kaufer, R.A. Kenny, A. Korczyn, K. Kosaka, V.M. Lee, A. Lees, I. Litvan, E. Londos, O.L. Lopez, S. Minoshima, Y. Mizuno, J.A. Molina, E.B. Mukaetova-Ladinska, F. Pasquier, R.H. Perry, J.B. Schulz, J.Q. Trojanowski, and M. Yamada Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 2005 1863 1872 (Pubitemid 43970103)
19. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
20. G.M. McKhann, M.S. Albert, M. Grossman, B. Miller, D. Dickson, and J.Q. Trojanowski Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch. Neurol. 58 2001 1803 1809 (Pubitemid 33044246)
21. D. Neary, J. Snowden, and D. Mann Frontotemporal dementia Lancet Neurol. 4 2005 771 780 (Pubitemid 41457293)
22. A. Olsson, K. Hoglund, M. Sjogren, N. Andreasen, L. Minthon, L. Lannfelt, K. Buerger, H.J. Moller, H. Hampel, P. Davidsson, and K. Blennow Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients Exp. Neurol. 183 2003 74 80 (Pubitemid 37075858)
23. R.M. Page, K. Baumann, M. Tomioka, B.I. Perez-Revuelta, A. Fukumori, H. Jacobsen, A. Flohr, T. Luebbers, L. Ozmen, H. Steiner, and C. Haass Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation J. Biol. Chem. 283 2008 677 683
24. M.R. Palmert, M. Usiak, R. Mayeux, M. Raskind, W.W. Tourtellotte, and S.G. Younkin Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease Neurology 40 1990 1028 1034 (Pubitemid 20213966)
25. K. Sennvik, J. Fastbom, M. Blomberg, L.O. Wahlund, B. Winblad, and E. Benedikz Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients Neurosci. Lett. 278 2000 169 172 (Pubitemid 30009484)
26. M. Vandermeeren, M. Mercken, E. Vanmechelen, J. Six, A. van de Voorde, J.J. Martin, and P. Cras Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J. Neurochem. 61 1993 1828 1834 (Pubitemid 23317209)
27. H. Vanderstichele, E. Van Kerschaver, C. Hesse, P. Davidsson, M.A. Buyse, N. Andreasen, L. Minthon, A. Wallin, K. Blennow, and E. Vanmechelen Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma Amyloid. 7 2000 245 258
28. E. Vanmechelen, H. Vanderstichele, P. Davidsson, E. Van Kerschaver, B. Van Der Perre, M. Sjogren, N. Andreasen, and K. Blennow Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization Neurosci. Lett. 285 2000 49 52 (Pubitemid 30224621)
29. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741 (Pubitemid 129515714)
30. 181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease J. Neural Transm. 116 2009 203 212
31. J. Wiltfang, H. Esselmann, M. Bibl, A. Smirnov, M. Otto, S. Paul, B. Schmidt, H.W. Klafki, M. Maler, T. Dyrks, M. Bienert, M. Beyermann, E. Ruther, and J. Kornhuber Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation J. Neurochem. 81 2002 481 496 (Pubitemid 34809327)
32. J. Wiltfang, H. Esselmann, M. Bibl, M. Hull, H. Hampel, H. Kessler, L. Frolich, J. Schroder, O. Peters, F. Jessen, C. Luckhaus, R. Perneczky, H. Jahn, M. Fiszer, J.M. Maler, R. Zimmermann, R. Bruckmoser, J. Kornhuber, and P. Lewczuk Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load J. Neurochem. 101 2007 1053 1059 (Pubitemid 46683864)
33. H. Zetterberg, U. Andreasson, O. Hansson, G. Wu, S. Sankaranarayanan, M.E. Andersson, P. Buchhave, E. Londos, R.M. Umek, L. Minthon, A.J. Simon, and K. Blennow Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease Arch. Neurol. 65 2008 1102 1107
34. Z. Zhong, M. Ewers, S. Teipel, K. Burger, A. Wallin, K. Blennow, P. He, C. McAllister, H. Hampel, and Y. Shen Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment Arch. Gen. Psychiatry 64 2007 718 726 (Pubitemid 46878672)